Effect of dimethylbenzyldesmethylrifampicin (DMB) on chemically induced mammary tumours in rats.
D000273:Adipose Tissue / Q000378:metabolism; D000284:Administration, Oral; D000818:Animals; D000903:Antibiotics, Antineoplastic; D001551:Benz(a)Anthracenes; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D005260:Female; D007274:Injections, Intraperitoneal; D007413:Intestinal Mucosa / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008325:Mammary Neoplasms, Experimental / Q000517:prevention & control*; D009132:Muscles / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000139:chemically induced; D051381:Rats; D012293:Rifampin / Q000097:blood; D012294:Rifamycins / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D013154:Spleen / Q000378:metabolism; D014316:Tritium
D000903:Antibiotics, Antineoplastic; D001551:Benz(a)Anthracenes; D001593:Benzyl Compounds; D012294:Rifamycins; D014316:Tritium; D012293:Rifampin